ARTL
NASD Artelo Biosciences Inc$3.37 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.37, $0.14 below the day’s high of $3.51
- YTD change
- -89.77%
- vs 20-day SMA
- -23.84%
- vs 200-day SMA
- -86.44%
Price ranges
Price & Performance
-3.47 (-50.73%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $12,150.00
- ARTL is down 90% since the beginning of the year
- ARTL is down 97% over the past 12 months
- ARTL is down 44% over the past 1 month
- 4% of all ARTL investors are betting against ARTL
ARTL reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -27.7%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -16.58%
- vs 8-day SMA
- -11.02%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.